本页面由Tiger Trade Technology Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

30.21
-0.6100-1.98%
盘后:30.210.00000.00%19:30 EDT
成交量:116.87万
成交额:3,538.35万
市值:17.97亿
市盈率:-4.31
高:30.99
开:30.60
低:30.10
收:30.82
52周最高:46.00
52周最低:22.24
股本:5,947.16万
流通股本:5,008.85万
量比:0.90
换手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):-7.0075
每股收益(LYR):-7.1203
净资产收益率:-34.34%
总资产收益率:-22.24%
市净率:1.75
市盈率(LYR):-4.24

数据加载中...

2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities